ANTI-TUMOR ACTIVITY AND PLASMA KINETICS OF BLEOMYCIN BY CONTINUOUS AND INTERMITTENT ADMINISTRATION

被引:41
作者
PENG, YM
ALBERTS, DS
CHEN, HSG
MASON, N
MOON, TE
机构
[1] UNIV ARIZONA,COLL MED,DEPT MED,HEMATOL & ONCOL SECT,TUCSON,AZ 85724
[2] UNIV ARIZONA,COLL MED,CTR CANC,TUCSON,AZ 85724
关键词
D O I
10.1038/bjc.1980.110
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:644 / 647
页数:4
相关论文
共 13 条
  • [1] ALBERTS DS, 1978, CANCER CHEMOTH PHARM, V1, P177
  • [2] ALBERTS DS, 1979, CANCER CHEMOTH PHARM, V2, P127
  • [3] ALBERTS DS, 1976, CANCER RES, V36, P2785
  • [4] BAKER LH, 1978, OBSTET GYNECOL, V52, P146
  • [5] BARRANCO SC, 1979, BLEOMYCIN CURRENT ST, P81
  • [6] BROUGHTON A, 1976, CANCER RES, V36, P1418
  • [7] MELLETT LB, 1973, PHARMACOLOGY FUTURE, V3, P332
  • [8] METZLER CM, 1969, 7292697292005 UPJ CO
  • [9] PENG YM, 1979, P AACR ASCO, V20, P202
  • [10] PRESTAYKO AW, 1979, BLEOMYCIN CURRENT ST, P117